Hjem › Multipelt myelom › Delaware
Kliniske studier for Multipelt myelom i Delaware
4 studier for Multipelt myelom søker deltakere på steder i Delaware.
Byer i Delaware
Offisiell studietekst (engelsk)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- ChristianaCare Helen F Graham Cancer Center and Research Institute, Newark
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05552222A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Medical Oncology Hematology Consultants /ID# 268560, Newark
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 13. jul. 2026 · NCT05650632Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
- Christiana Care, Newark
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 4. jun. 2026 · NCT05243797Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
- Medical Oncology Hematology Consultants, Newark
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. apr. 2026 · NCT05972135Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.